Journals / Turkish journal of vascular surgery / 2022 / Cilt: 31 - Sayı: 2

Risk factors and management of phlebitis-like abnormal reaction after cyanoacrylate closure of the truncal varicose vein insufficiency

Pages
78–85
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the present results, no dependent variable was found to be a risk factor for development of PLAR and a risk model could not be devised for the development of PLAR according to any dependent variable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to evaluate the incidence of phlebitis-like abnormal reaction (PLAR), possible risk factors for the reaction, and the management of PLAR after cyanoacrylate closure (CAC) of great saphenous vein (GSV) or small saphenous vein (SSV) in patients with chronic venous insufficiency (CVI).
📊
Key Findings & Data:Patients and methods: Between June 2020 and March 2021, a total of 90 patients (35 males, 55 females; mean age: 47.6±6.0 years; range, 28 to 69 years) who underwent CAC procedure for GSV or SSV insufficiency were retrospectively analyzed.
💡
Conclusion & Impact:According to the present results, no dependent variable was found to be a risk factor for development of PLAR and a risk model could not be devised for the development of PLAR according to any dependent variable.
🔬Design:Modeling & Simulation
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to evaluate the incidence of phlebitis-like abnormal reaction (PLAR), possible risk factors for the reaction, and the management of PLAR after cyanoacrylate closure (CAC) of great saphenous vein (GSV) or small saphenous vein (SSV) in patients with chronic venous insufficiency (CVI). Patients and methods: Between June 2020 and March 2021, a total of 90 patients (35 males, 55 females; mean age: 47.6±6.0 years; range, 28 to 69 years) who underwent CAC procedure for GSV or SSV insufficiency were retrospectively analyzed. The patients were divided into two groups: those with PLAR (Group 1) and no PLAR (Group 2). Both groups were compared in terms of possible risk factors. The primary goal was to evaluate the incidence, onset time, duration, severity and possible risk factors for PLAR and Venous Clinical Severity Score (VCSS) and Visual Analog Scale-Pain (VAS-pain) scores of the patients and to compare the groups one week after the procedure. The secondary goal was to evaluate the technical success, recanalization, mortality, major adverse events, and other postoperative complications. Results: No technical failure and device-related complications were encountered. Anatomic success rate was 100% after CAC procedures. The incidence of PLAR was 14 cases (15.5%). All mild or moderate PLARs occurred within a week of the procedures. During the six-month follow-up period, the target veins were completely occluded in all patients (100%) without any recanalization. Although older age (p=0.042), female sex (p=0.145), obesity (p=0.145), and history of drug allergy (p=0.131) were more common in the PLAR group, they did not reveal statistical significance. Logistic regression analysis revealed that no dependent variable was a risk factor associated with the development of PLAR. All PLAR cases were seen in the target GSV. Improvement in the VCSS scores were not statistically significant between baseline and the one-week control between two groups. Conclusion: Although PLAR can be seen at high incidence rates, it is a preventable complication with various technical modifications applied during CAC procedure as treatment strategies. According to the present results, no dependent variable was found to be a risk factor for development of PLAR and a risk model could not be devised for the development of PLAR according to any dependent variable.

🔖

Cite This Article

YİĞİT, G. (2022). Risk factors and management of phlebitis-like abnormal reaction after cyanoacrylate closure of the truncal varicose vein insufficiency. Turkish journal of vascular surgery, Cilt: 31 - Sayı: 2, 78–85. https://ajindex.com/articles/614483

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: A meta-analysis. J Vasc Surg 2009;49:230-9
  2. Gibson K, Morrison N, Kolluri R, Vasquez M, Weiss R, Cher D, et al. Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord 2018;6:606-13
  3. Kolluri R, Gibson K, Cher D, Madsen M, Weiss R, Morrison N. Roll-in phase analysis of clinical study of cyanoacrylate closure for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord 2016;4:407-15
  4. Yiğit G. Single center experience in vascular and endovascular surgery during the COVID-19 pandemic: Walking on the icy road. J Clinical Cardiology and Cardiovascular Interventions 2021;4:1-6
  5. Yiğit G. How effective is cyanoacrylate closure in small saphenous vein insufficiency? A single center experience. Vascular 2021:17085381211051494
  6. Proebstle TM, Alm J, Dimitri S, Rasmussen L, Whiteley M, Lawson J, et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord 2015;3:2-7
  7. Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of firstin-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord 2017;5:658-66
  8. Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Fiveyear extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord 2020;8:978-89
  9. Park I, Jeong MH, Park CJ, Park WI, Park DW, Joh JH. Clinical features and management of “phlebitis-like abnormal reaction” after cyanoacrylate closure for the treatment of incompetent saphenous veins. Ann Vasc Surg 2019;55:239-45
  10. Gibson K, Minjarez R, Rinehardt E, Ferris B. Frequency and severity of hypersensitivity reactions in patients after VenaSeal™ cyanoacrylate treatment of superficial venous insufficiency. Phlebology 2020;35:337-44
  11. Lee S, Cho S, Joh JH. Risk factors for complex hypersensitivity and irritation reactions after an ultrasound-guided cyanoacrylate closure. J Surg Ultrasound 2021;8:19-24
  12. Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saph